argenx Q2 FY26 profit rises 93% to $472 million; net sales increase 60% year-over-year to $1.52 billion

argenx SE

argenx SE

ARGX

0.00
  • argenx posted 2Q 2026 profit of $472 million, swinging from $245 million a year earlier; operating profit rose 146% year over year to $494 million.
  • Product net sales climbed 60% year over year to $1.52 billion, rising 17% from 1Q; 1H net sales rose to $2.81 billion.
  • R&D expenses increased to $486 million; SG&A costs rose to $417 million, reflecting VYVGART franchise commercialization and pipeline investment.
  • Expanded the U.S. label for VYVGART and VYVGART Hytrulo to all adult gMG serotypes, including triple seronegative patients.
  • Kept key readouts on track, with ALKIVIA myositis results due in 3Q26 and EMPASSION MMN data for empasiprubart expected in 4Q26.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. arGEN-X SE published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.